1. Home
  2. VIRC vs MAIA Comparison

VIRC vs MAIA Comparison

Compare VIRC & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virco Manufacturing Corporation

VIRC

Virco Manufacturing Corporation

HOLD

Current Price

$6.04

Market Cap

95.5M

ML Signal

HOLD

Logo MAIA Biotechnology Inc.

MAIA

MAIA Biotechnology Inc.

HOLD

Current Price

$1.30

Market Cap

77.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIRC
MAIA
Founded
1950
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
95.5M
77.1M
IPO Year
1995
2022

Fundamental Metrics

Financial Performance
Metric
VIRC
MAIA
Price
$6.04
$1.30
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$7.30
N/A
AVG Volume (30 Days)
30.3K
585.8K
Earning Date
04-08-2026
05-12-2026
Dividend Yield
1.65%
N/A
EPS Growth
N/A
33.33
EPS
0.16
N/A
Revenue
$199,652,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$19.77
N/A
P/E Ratio
$38.25
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.16
$0.87
52 Week High
$9.07
$3.19

Technical Indicators

Market Signals
Indicator
VIRC
MAIA
Relative Strength Index (RSI) 48.44 44.39
Support Level $6.02 $1.20
Resistance Level $6.44 $1.46
Average True Range (ATR) 0.15 0.09
MACD -0.00 0.01
Stochastic Oscillator 29.72 33.19

Price Performance

Historical Comparison
VIRC
MAIA

About VIRC Virco Manufacturing Corporation

Virco Manufacturing Corp is engaged in designing, production and distributing quality furniture for the commercial and education markets. The company manufactures an assortment of products, including mobile tables, mobile storage equipment, desks, computer furniture, chairs, activity tables, folding chairs, and folding tables. Its primary furniture lines are constructed of tubular metal legs and frames, combined with wood and plastic tops, plastic seats and backs, upholstered seats and backs, and upholstered rigid polyethylene and polypropylene shells.

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of targeted immunotherapies for cancer, with an initial focus on non-small cell lung cancer (NSCLC), which represents the majority of lung cancer cases. Its asset, ateganosine (THIO, also known as 6-thio-dG or 6-thio-deoxyguanosine), is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The treatment approach involves administering THIO followed by the immune checkpoint inhibitor Libtayo (cemiplimab), which is manufactured and commercialized by Regeneron.

Share on Social Networks: